PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 117 filers reported holding PULMONX CORP in Q4 2022. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $189,111 | -18.3% | 18,307 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $231,457 | +25.4% | 17,655 | +7.0% | 0.00% | 0.0% |
| Q1 2023 | $184,548 | +35.3% | 16,507 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $136,381 | -49.7% | 16,178 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $271,000 | +14.8% | 16,237 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $236,000 | -26.7% | 16,007 | +23.5% | 0.00% | 0.0% |
| Q1 2022 | $322,000 | -27.6% | 12,963 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $445,000 | -13.4% | 13,875 | -2.9% | 0.00% | -33.3% |
| Q3 2021 | $514,000 | -18.2% | 14,290 | +0.4% | 0.00% | +50.0% |
| Q2 2021 | $628,000 | +102.6% | 14,231 | +110.3% | 0.00% | +100.0% |
| Q1 2021 | $310,000 | -33.5% | 6,767 | +0.3% | 0.00% | -50.0% |
| Q4 2020 | $466,000 | – | 6,749 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG-WTT Global Life Science Capital Partners GP Ltd | 60,204 | $886,000 | 3.13% |
| PURA VIDA INVESTMENTS, LLC | 1,327,065 | $19,534,000 | 1.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,465,901 | $51,018,000 | 1.05% |
| NEXT CENTURY GROWTH INVESTORS LLC | 453,098 | $6,669,000 | 0.87% |
| Novo Holdings A/S | 510,555 | $7,515,000 | 0.37% |
| Rock Springs Capital Management LP | 702,400 | $10,339,000 | 0.30% |
| RTW INVESTMENTS, LP | 691,255 | $10,175,000 | 0.26% |
| TimesSquare Capital Management, LLC | 1,214,204 | $17,873,000 | 0.25% |
| FORMULA GROWTH LTD | 54,951 | $809,000 | 0.22% |
| Champlain Investment Partners, LLC | 2,129,760 | $31,350,000 | 0.20% |